Sponsor Pipeline

Ranok Therapeutics (Hangzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07303465 To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic… KRAS G12D Mutations Recruiting
Phase 1/2
NCT05487170 A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma… Advanced Solid Tumor Recruiting
NCT06667544 A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat… KRAS G12D Mutation Recruiting
Phase 1
NCT07334262 A Study to Evaluate the Food Effect on RNK08954 in Healthy Participants, and the Mass… Food Effect Not Yet Recruiting
Disease Areas
Get alerts when Ranok Therapeutics (Hangzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free